MedTrace Logo

Timing of VTE Prophylaxis in TBI

NCT03081169 · Status: WITHDRAWN · Phase: PHASE4 · Type: INTERVENTIONAL

Last updated 2019-08-16

No results posted yet for this study

Summary

This study compares the efficacy and complication rates of early (24 hours) versus late (72 hours) VTE prophylaxis administration to TBI patients. Patients in both treatment groups will be monitored for development of VTE as well as complications from bleeding after commencement of VTE prophylaxis.

Conditions

  • TBI (Traumatic Brain Injury)
  • VTE (Venous Thromboembolism)

Interventions

DRUG

Enoxaparin Sodium 150 MG/ML Prefilled Syringe

The same drugs and dosages will be used in both groups, with only the timing being different

DRUG

Heparin

The same drugs and dosages will be used in both groups, with only the timing being different

Sponsors & Collaborators

  • Loyola University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-03
Primary Completion
2019-08-12
Completion
2019-08-12
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03081169 on ClinicalTrials.gov